Recognition, assessment and management of eosinophilic oesophagitis

Arch Dis Child. 2013 Sep;98(9):702-6. doi: 10.1136/archdischild-2012-302838. Epub 2013 Jun 28.

Abstract

Eosinophilic oesophagitis (EO) is a chronic immune/antigen-mediated oesophageal disease, with the immune reaction most likely directed to foods but on occasion also to aeroallergens. Clinically, it is characterised by symptoms of oesophageal dysfunction in subjects who typically have other indicators of an atopic tendency. Older children (and adults) frequently present with dysphagia and can have strictures (which may require dilatation). The diagnosis is dependent on an eosinophil-predominant oesophageal inflammation, with 15 or more eosinophils per high-powered field, now generally accepted as a necessary cut-off level of infiltration, which together with other clinical data (eg, oesophageal pH/impedance studies) can help discriminate EO from other potential causes of symptoms such as gastro-oesophageal reflux disease. Recommended therapies, which may need to be long term, are dietary antigen exclusion (with elemental feeds or an exclusion diet) and/or topical corticosteroids.

Keywords: Allergy; Gastroenterology.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use*
  • Diagnosis, Differential
  • Dilatation / adverse effects
  • Dilatation / methods*
  • Eosinophilic Esophagitis / diagnosis*
  • Eosinophilic Esophagitis / drug therapy
  • Eosinophilic Esophagitis / therapy
  • Eosinophils / immunology*
  • Eosinophils / pathology
  • Esophagus / immunology
  • Esophagus / pathology*
  • Humans
  • Proton Pump Inhibitors / adverse effects
  • Proton Pump Inhibitors / therapeutic use*
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Proton Pump Inhibitors